TERN
Terns Pharmaceuticals Inc
Price:  
6.73 
USD
Volume:  
2,109,363.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TERN WACC - Weighted Average Cost of Capital

The WACC of Terns Pharmaceuticals Inc (TERN) is 6.3%.

The Cost of Equity of Terns Pharmaceuticals Inc (TERN) is 7.70%.
The Cost of Debt of Terns Pharmaceuticals Inc (TERN) is 5.00%.

Range Selected
Cost of equity 6.10% - 9.30% 7.70%
Tax rate 0.50% - 0.80% 0.65%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.6% - 7.1% 6.3%
WACC

TERN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 9.30%
Tax rate 0.50% 0.80%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.6% 7.1%
Selected WACC 6.3%